Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...
As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
US President Donald Trump kicked off his second term with a series of directives aimed at the US National Institutes of ...
GlobalData on MSN1d
Royalty Pharma pays $250m for rights to Biogen’s lupus drugRoyalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...
In the rapidly evolving digital era, the pharmaceutical industry faces significant cybersecurity challenges, where data ...
GlobalData on MSN9d
Trump’s tariffs could strain medicine supply and drive drug costsIndustry associations react to President Trump’s tariffs and what they could mean for the pharmaceutical supply chain.
The innovations highlighted by Sreeharsha Amarnath Rongala mark a pivotal shift in the evolution of pharmaceutical ERP ...
Shardul Nautiyal, Mumbai Monday, February 10, 2025, 14:30 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback